The authors investigated the effect of 3-mercaptopicolinic acid, a phosphoenolpyruvate carboxykinase (PEPCK) inhibitor, on C2C12 muscle cells. They report that Pck2 mRNA was 50–5000-fold higher than Pck1 during C2C12 myogenesis, indicating Pck2 is the predominant PEPCK isoform.
[Scientific Reports]
1254621
{1254621:N6T6KUE5}
apa
50
1
157383
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/